以质量求发展,以服务铸品牌

护理学报 ›› 2022, Vol. 29 ›› Issue (8): 40-45.doi: 10.16460/j.issn1008-9969.2022.08.040

• 循证护理 • 上一篇    下一篇

急性白血病患者化疗相关便秘预防和管理的循证护理实践

姚晶晶1, 刘颖1,2, 许汇娟1, 孙思敏1, 陈敏1, 江雪杰1   

  1. 1.南方医科大学南方医院 血液科,广东 广州 510515;
    2.南方医院JBI循证护理合作中心,广东 广州 510515
  • 收稿日期:2021-07-27 出版日期:2022-04-25 发布日期:2022-05-11
  • 通讯作者: 刘颖(1990-),女,河南项城人,硕士,护师,澳大利亚JBI循证卫生保健中心证据转化培训师。E-mail:1113722345@qq.com
  • 作者简介:姚晶晶(1981-),女,湖北荆州人,本科学历,主管护师。
  • 基金资助:
    广东省自然科学基金-面上项目(2019A1515012055); 2018年度南方医院护理创优-循证实践专项项目(2018EBNc005)

Prevention and Management of Chemotherapy-induced Constipation in Patients with Acute Leukemia: A Evidence-based Nursing Practice Project

YAO jing-jing1, LIU Ying1,2, XU Hui-juan1, SUN Si-min1, CHEN Min1, JIANG Xue-jie1   

  1. 1. Dept. of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;
    2. Nanfang Nursing Centre for Evidence-based Practice: A JBI Centre of Excellence, Guangzhou 510515, China
  • Received:2021-07-27 Online:2022-04-25 Published:2022-05-11

摘要: 目的 制定恶性肿瘤患者化疗相关便秘(chemotherapy-induced constipation, CIC)的最佳预防和管理策略,结合急性白血病化疗患者的临床特点、个体需求及本院当前的医疗资源等,将最佳证据应用于临床以改善患者化疗后排便情况。方法 遵循JBI 临床证据实践应用模式,包括证据应用前基线审查、证据应用实践变革及证据应用后效果再审查3 个阶段。将最佳证据转化成8条审查指标,应用于急性白血病患者。比较证据应用前后护士对最佳证据的执行率,患者化疗前1周和化疗后1周内排便次数以及排便形态为Bristol I、II型的次数。结果 证据应用后,护士对CIC预防和管理的各项证据的执行率显著升高(P<0.001);患者化疗开始后1周内排便次数、出现Bristol Ⅰ和Ⅱ型粪便形态的次数较化疗前1周均无显著差异(P>0.05)。结论 基于最佳证据的CIC预防和管理策略应用于急性白血病患者后,能够提高护士对各项审查指标依从性,可预防和改善急性白血病患者化疗后排便状况。

关键词: 急性白血病, 化疗, 便秘, 循证实践

Abstract: Objective To develop the best prevention and management strategies for chemotherapy-induced constipation (CIC) in patients with malignant tumors, to apply the best evidence in clinical practice to enhance the outcome of CIC in acute leukemia patients based on the clinical characteristics of the patients, individual needs and current medical resources of the hospital. Methods The JBI clinical evidence practice application model was followed, including baseline audit, evidence application practice reform and effect assessment after evidence application. The best evidence was translated into eight review indicators and applied to patients with acute leukemia. The compliance rate of the best evidence by nurses before and after evidence application, the patient's compliance with self-assessment of symptoms, the number of patients defecating 1 week before and 1 week after chemotherapy, as well as the number of Bristol I and II defecation patterns were compared. Results After evidence application, nurses' compliance rates of the precautions and management strategies of CIC were significantly improved (P<0.001); there were no significant differences in the number of defecation and the number of Bristol I and II fecal morphology within 1 week after chemotherapy when compared with that before chemotherapy (P>0.05). Conclusion Best evidence-based strategies for the prevention and management of CIC in patients with acute leukemia can enhance the compliance of nurses with all of the audits and improve defecation after chemotherapy in patients with acute leukemia.

Key words: acute leukemia, chemotherapy, chemotherapy-induced constipation, evidence-based practice

中图分类号: 

  • R473.55
[1] Xue H, Sawyer MB, Wischmeyer PE, et al.Nutrition Modulation of Gastrointestinal Toxicity Related to Cancer Chemotherapy: From Preclinical Findings to Clinical Strategy[J]. J Parenter Enteral Nutr, 2011, 35(1):74-90. DOI:10.1177/0148607110377338.
[2] 王月峰, 李峻岭. 肿瘤患者化疗引起相关便秘的临床诊治[J]. 癌症进展,2015,13(6):11-13.DOI:10.11877/j.issn.1672-1535.2015.13.06.02.
[3] Connolly M, Larkin P. Managing Constipation: A Focus on Care and Treatment in the Palliative Setting[J]. Br J Community Nurs, 2012, 17(2):60, 62-64, 66-67. DOI:10.12968/bjcn.2012.17.2.60.
[4] Stojanovska V,Sakkal S,Nurgali K.Platinum-based Chemotherapy:Gastrointestinal Immunomodulation and Enteric Nervous System Toxicity[J]. Am J Physiol Gastrointest Liver Physiol, 2015,308(4):G223-G232.DOI:10.1152/ajpgi.00212.2014.
[5] Dukas L, Willett WC, Giovannucci EL.Association between Physical Activity, Fiber Intake, and other Lifestyle Variables and Constipation in a Study of Women[J]. Am J Gastro enterol,2003,98(8):1790-1796.DOI:10.1111/j.1572-0241.2003.07591.x.
[6] 李昌跃,田正良. 腹部按摩联合贝飞达预防急性白血病患者化疗后便秘的效果观察[J].中国社区医师,2016,32(8):107-108. DOI:10.3969/j.issn.1007-614x.2016.8.65.
[7] Leung L, Riutta T, Kotecha J, et al.Chronic Constipation: An Evidence-based Review[J].J Am Board Fam Med, 2011, 24(4):436-451. DOI:10.3122/jabfm.2011.04.100272.
[8] 王琼. 血液肿瘤患者化疗并发症及影响因素分析[J].中国肿瘤临床与康复, 2014(9):1140-1142. DOI:10.13455/j.cnki.cjcor.2014.09.39.
[9] 顾莺, 张慧文, 周英凤,等. JBI循证卫生保健中心关于不同类型研究的质量评价工具——系统评价的方法学质量评价[J]. 护士进修杂志, 2018, 33(8):33-35. DOI:10.16821/j.cnki.hsjx.2018.08.008.
[10] Brouwers MC, Kho ME, Browman GP, et al.AGREE II: Advancing Guideline Development, Reporting, and Evaluation in Health Care[J]. Can Med Assoc J, 2010,182(18): E839. DOI:10.1503/cmaj.090449.
[11] 王青春,胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J].护士进修杂志 , 2015,30(11):964-967.
[12] Jing X, Liu J, Wang C, et al.Auricular Acupressure is an Alternative in Treating Constipation in Leukemia Patients Undergoing Chemotherapy:A Systematic Review and Meta-analysis[J]. Complement Ther Clin Pract, 2018(31):282-289. DOI:10.1016/j.ctcp.2018.03.005.
[13] 惠靖瑞, 熊振芳, 陈涵彬,等. 神阙穴贴敷治疗肿瘤患者化疗相关性便秘疗效的Meta分析[J]. 护理学报, 2020, 27(2):38-42. DOI:10.16460/j.issn1008-9969.2020.02.038.
[14] Manuel B. Evidence Summary.Chemotherapy-Induced Constipation:Management [EB/OL].(2020-03-29)[2021-03-04].https://ovidsp.dc2.ovid.com/ovia/ovidweb.cgi?&S=EPNEFPEEDBEBPEOBJPOJHFHGAGNMAA00&Complete+Reference
=S.sh.18%7c1%7c1&Counter5=SS_view_found_complete%7cJBI960%7cjbi%7cjbidb%7cjbi&Counter5Data=JBI960%7cjbi%7cjbidb%7cjbi
[15] Pamaiahgari P. Evidence Summary. Constipation in Hospitalized Patients: Management[EB/OL].(2020-03-23) [2021-03-04].https://ovidsp.dc2.ovid.com/ovida/ovidweb.cgi?&S=EPNEFPEEDBEBPEOBJPOJHFHGAGNMAA00&Link+Set=S.sh. 37%7c1%7csl_190.
[16] Owaya A. Evidence Summary. Constipation: Assessment of Hospitalized Patients[EB/OL].(2021-03-01)[2021-03-26]. https://ovidsp.dc2.ovid.com/ovida/ovidweb.cgi?&S=EPNEFPEEDBEBPEOBJPOJHFHGAGNMAA00&Link+Set=S.sh.45%7c1%7csl_190.
[17] 姚小云, 陈红宇, 胡君娥,等. 癌症患者化疗相关性便秘评估与管理最佳证据总结[J]. 护理学报, 2020, 27(2):48-52. DOI:10.16460/j.issn1008-9969.2020.02.048.
[18] Rogers B, Ginex PK, Anbari A, et al.ONS Guidelines for Opioid-induced and Non-opioid-related Cancer Constipation[J]. ONF, 2020,47(6):671-691.DOI:10.1188/20.ONF.671-691.
[19] Davies A, Leach C, Caponero R, et al.MASCC Recommendations on the Management of Constipation in Patients with Advanced Cancer[J]. Support Care Cancer, 2020, 28(1):23-33. DOI:10.1007/s00520-019-05016-4.
[20] Larkin PJ, Cherny NI, La Carpia D, et al.Diagnosis, Assessment and Management of Constipation in Advanced Cancer: ESMO Clinical Practice Guidelines[J]. Ann Oncol, 2018,29(S4):111-125. DOI:10.1093/annonc/mdy148.
[21] 安彬彬, 叶素笑, 孙成慢. 社区老年人慢性功能性便秘的发生现状及相关因素分析[J]. 中华现代护理杂志, 2016, 22(27):3932-3934. DOI:10.3760/cma.j.issn.1674-2907.2016.27.021.
[22] Abarado C.Improving Constipation Management in Oncology:A Unit-level Implementation of Constipation Risk Assessment Scale(2009-2010)[J]. J Geriatr Oncol,2014,5(2):S67. DOI:10.1016/j.jgo.2014.09.121.
[23] Ma X, Lu Q, Lu Y, et al.Validation of the Constipation Risk Assessment Scale (CRAS) in Chinese Cancer Patients[J]. Eur J Oncol Nurs, 2021,50(3):101895. DOI:10.1016/j.ejon.2021.101895.
[24] McMillan SC, Williams FA. Validity and Reliability of the Constipation Assessment Scale[J]. Cancer Nurs,1989, 12(3):183-188. DOI:10.1097/00002820-198906000-00012.
[25] 王冲, 吴艳, 邵静. 综合排便管理在女性精神疾病住院患者中的临床应用[J]. 中国实用护理杂志, 2019, 35(6):446-450. DOI:10.3760/cma.j.issn.1672-7088.2019.06.011.
[26] 宋玉磊,林征,林琳,等.中文版便秘患者症状自评量表的信度与效度研究[J]. 护理学杂志, 2012, 27(4):73-76. DOI:10.3870/hlxzz.2012.07.073.
[27] Dehghan M, Malakoutikhah A, Ghaedi Heidari F, et al.The Effect of Abdominal Massage on Gastrointestinal Functions: A Systematic Review[J]. Complement Ther Med,2020(54):102553. DOI: 10.1016/j.ctim.2020.102553.
[28] Santacruz CC, López MO, García MV, et al.Do Bad Habits bring a Double Constipation Risk?[J].Turk J Gastroenterol, 2018, 29(5):580-587. DOI:10.5152/tjg.2018.17533.
[1] 郭林芳, 张培莉, 侯晓雅, 李滢, 曹敏, 高超越. 肝癌化疗患者线上线下结合营养干预方案的构建[J]. 护理学报, 2025, 32(4): 1-5.
[2] 刘璐, 朱钰, 曹义, 张华, 彭玉娜. 腹腔热灌注化疗患者术中实施不同目标体温管理的效果观察[J]. 护理学报, 2025, 32(4): 59-63.
[3] 曹敏, 张培莉, 侯晓雅, 高超越, 郭林芳, 李滢. ABC-X模型下结直肠癌化疗患者照顾者营养照护体验的质性研究[J]. 护理学报, 2025, 32(2): 13-18.
[4] 夏碧芸, 陈瑜, 吴彦妍, 胡雁. 降低经桡动脉冠状动脉介入术后老年患者桡动脉闭塞发生的循证实践[J]. 护理学报, 2025, 32(2): 37-43.
[5] 刘琪, 刘佳丽, 刘玉, 杨丽敏, 范育英, 吕星, 覃惠英. 鼻咽癌患者诱导化疗序贯同期放化疗期间躯体-心理症状负担轨迹及影响因素研究[J]. 护理学报, 2025, 32(1): 1-6.
[6] 李春萍, 张兰萍, 王晓辉, 钟乐欣, 杨薇, 赵青, 吕森森, 李嘉琪, 谢昀筠, 黄婉晴, 陈晓珊, 徐东. 实施理论—常态化过程理论的解读[J]. 护理学报, 2024, 31(5): 39-43.
[7] 李苗, 李红梅, 张俊, 李盼盼, 张宇彤, 王茜, 李沁瑶. 乳腺癌化疗患者自我倡权潜在类别及影响因素分析[J]. 护理学报, 2024, 31(20): 19-23.
[8] 张淑珍, 余文汝, 张俊峰, 江佳瑶, 罗美, 林碧玉, 麦敏雯, 杨梦婷. 肿瘤放疗患者放射性皮炎预防与管理的循证护理实践[J]. 护理学报, 2024, 31(16): 62-66.
[9] 刘瑶, 詹欣, 谢亭平, 陈炜, 胡依阳, 杨翠娜, 张国忠. 脑血管造影术后使用股动脉压迫止血器患者早期活动的循证实践[J]. 护理学报, 2024, 31(15): 29-33.
[10] 戴美芬, 梁钰贞, 杨静, 尤燕燕, 杨清, 昌广婷, 区幸莹, 黄传蔷, 陈智星, 区洁芬. 基于循证和中医理念的乳腺癌化疗患者癌因性疲乏护理干预方案的构建[J]. 护理学报, 2024, 31(15): 34-38.
[11] 冯丽娜, 田金丽, 李娟, 陈辰, 徐晓彤, 朱晓萌, 贺瑾. 淋巴瘤患者化疗期Connect-Home过渡护理干预方案的构建[J]. 护理学报, 2024, 31(15): 57-61.
[12] 邓颖一, 程露颖, 龚喜燕, 王敏, 廖冬霞, 张翠翠, 丁娟, 古清鹭, 廖常菊. 临床护理交接班循证实践的范围综述[J]. 护理学报, 2024, 31(14): 57-62.
[13] . 基于HFMEA方法优化日间化疗病房工作流程的研究[J]. 护理学报, 2024, 31(12): 26-31.
[14] 陈茜, 胡露红, 孙玲, 高娉婷, 王璐, 祝贤惠. 多学科协作背景下乳腺癌化疗外周神经毒性症状护理方案的构建与应用[J]. 护理学报, 2023, 30(8): 34-38.
[15] 刘爱华, 刘卓, 李敏, 李洪言, 李珺, 肖兰, 陈成, 李静. 基于单元的综合安全项目在复发性卵巢癌化疗患者安全用药中的应用[J]. 护理学报, 2023, 30(6): 22-25.
Viewed
Full text


Abstract

Cited

  Shared   
No Suggested Reading articles found!